Keating Financial Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Sell
175
-12
-6% -$799 ﹤0.01% 1188
2026
Q1
$11.7K Buy
187
+82
+78% +$5.71K ﹤0.01% 1080
2025
Q4
$6.97K Buy
+105
New +$6.79K ﹤0.01% 1197

Other funds holding DXCM

Keating Financial Advisory Services's DXCM Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its DexCom (DXCM) stake by 6.4% in Q2 2026, selling an estimated $799 and leaving 175 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Keating Financial Advisory Services first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Keating Financial Advisory Services held 175 shares of DexCom worth $11.8K as of Q2 2026.
  • Keating Financial Advisory Services sold 12 DexCom shares in Q2 2026, an estimated $799.
  • DexCom made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1188 holding.
  • Keating Financial Advisory Services first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.